The Impact of Delay Between Biologic Prescription and Therapy Initiation on Clinical Outcomes in Inflammatory Bowel Disease Patients

被引：3
|
作者：
Agrawal, Manasi
Tepler, Adam
Hong, Simon
Advani, Rashmi
Lukin, Dana
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Northwell Hlth, Lenox Hill Hosp, New York, NY USA
[3] Weill Cornell Med Ctr, New York, NY USA
来源：
GASTROENTEROLOGY | 2019年 / 157卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2019.05.017
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [21] OUTCOMES OF TREATMENT FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGIC THERAPY
    Ramos, Guilherme Piovezani
    Stroh, Gregory
    Al-Bawardy, Badr
    Faubion, William
    Papadakis, Konstantinos A.
    Escalante, Patricio
    GASTROENTEROLOGY, 2017, 152 (05) : S579 - S580
  • [22] Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease
    Petersen, Sofie Ronja
    Rasmussen, Nathalie Fogh
    Donskov, Agnete Overgaard
    Thygesen, Lau Caspar
    Olsen, Kim Rose
    Ahrenfeldt, Linda Juel
    Andersen, Vibeke
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [23] Discussion on the biologic therapy of inflammatory bowel disease
    Merger, M
    Herfarth, H
    Scholmerich, J
    Andus, T
    Färber, L
    GASTROENTEROLOGY, 2003, 124 (07) : 2005 - 2006
  • [24] Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease
    Samnani, Sunil
    Wong, Emily C. L.
    Hamam, Hasan
    Dulai, Parambir S.
    Marshall, John K.
    Jairath, Vipul
    Reinisch, Walter
    Narula, Neeraj
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [25] Biologic Therapy in Inflammatory Bowel Disease Preface
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : XV - XVII
  • [26] Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
    Milo, F.
    Angelino, G.
    Romeo, E. F.
    De Angelis, P.
    Tabarini, P.
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [27] Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission
    F. Milo
    G. Angelino
    E.F. Romeo
    P. De Angelis
    P. Tabarini
    BMC Gastroenterology, 23
  • [28] Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a US Inflammatory Bowel Disease Cohort
    Nguyen, Vu Q.
    Jiang, Dingfeng
    Hoffman, Sharon N.
    Guntaka, Srikar
    Mays, Jessica L.
    Wang, Anthony
    Gomes, Joseph
    Sorrentino, Dario
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1825 - 1831
  • [29] Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease
    Shah, Nisha
    Cherry, Laura
    Zuckerman, Autumn
    Vimalathas, Praveen
    Choi, Leena
    Donoho, Charles A.
    Pabla, Baldeep
    Scoville, Elizabeth
    Dalal, Robin
    Beaulieu, Dawn
    Schwartz, David
    Horst, Sara
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S385 - S385
  • [30] Impact of Ustekinumab Trough Levels on Clinical Outcomes in Patients With Inflammatory Bowel Disease
    Nolan, Lindsey
    Meadors, Crystal
    Mcpheeters, Chelsey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S18 - S19
12345